(833) 317-6278
Book a Demo
Max Bayer
Gray shield icon
Is this you?
Claim your profile.

Max Bayer

Staff Writer

AS SEEN ON
Endpoints News

Preston's Summary

Max Bayer is a Staff Writer for Biotech, with his work also appearing in Fierce Pharma. Max specializes in covering the biotechnology industry, with a focus on pipeline developments, drug advancements, investment trends, and executive appointments. His articles provide in-depth analysis and insights into the rapidly evolving world of biotech.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

United States (National)

Coverage Attributes:

Beta
Press Release: 39 %
Government Announcement: 15 %
Cites Data: 14 %
Private Sector Announcements: 12 %
Legal Policy Regulation: 4 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Health News
  • Immunology

Pitching Insights

Max Bayer's coverage primarily focuses on the healthcare and pharmaceutical industry, specifically on biotech, drug development, FDA approvals, and clinical trials. His articles often contain press releases and cite data from private sector announcements.

To effectively reach out to Max Bayer, consider providing pitches related to groundbreaking advancements in biotechnology or pharmaceuticals with a focus on new drug applications, significant leadership changes within prominent companies in the industry, as well as noteworthy partnerships or deals between key players. Additionally, offering insights supported by reliable data could enhance the appeal of your pitch.

Given that Max Bayer does not have a specific geographic focus mentioned but covers global developments within the healthcare and pharmaceutical sectors, ensure that your pitches reflect international relevance rather than being region-specific.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Nicole Defeudis

Nicole Defeudis

Editor
*****e@********om
Publications
Endpoints News
Most recent topics
Not enough data
Paul Schloesser

Paul Schloesser

Associate Editor
Publications
Endpoints News
Most recent topics
Not enough data
Amber Tong

Amber Tong

Senior Editor
****r@**************com
Publications
Bloomberg News, Endpoints News, Boston Globe Technology, BNN Bloomberg, The Spokesman-Review
Most recent topics
Not enough data
Max Gelman

Max Gelman

Senior Editor
**x@**************com
Publications
Endpoints News
Most recent topics
Not enough data
Reynald Castaneda

Reynald Castaneda

********da@********om
Publications
Endpoints News, NewsBreak
Most recent topics
Not enough data
Ayisha Sharma

Ayisha Sharma

Biopharma Breaking News Reporter
******a@********om
Publications
Endpoints News, NewsBreak
Most recent topics
Not enough data

Articles

© 2024 Intelligent Relations